8247 — BioSino Bio-technology and Science Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Market Cap
HK$101.30m
Enterprise Value
HK$219.29m
Revenue
CNY289.07m

Annual balance sheet for BioSino Bio-technology and Science, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	54.5	45.5	44.5	77.3	63.4
Net Total Accounts Receivable
Net Total Receivables	273	242	257	247	180
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	426	387	408	397	350
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	122	130	107	85.2	83.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	645	625	608	603	563
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	363	379	389	346	321
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	470	447	432	397	353
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	175	177	176	206	210
Total Liabilities & Shareholders' Equity	645	625	608	603	563
Total Common Shares Outstanding